Evaluation of Safety and Tolerability of Libella Gene Therapy for the Treatment of Aging: AAV- hTERT
Clinical trial NCT04133649 · UNKNOWN
Trial details
- NCT number
- NCT04133649
- Sponsor
- Libella Gene Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-17
- Primary completion
- 2021-01-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.